Company: PETVW
Filing Date: 2025-03-31
Form Type: 8-K/A
Source: 0001641172-25-001616
Chunk: 1

Company: PetVivo Holdings, Inc.
Filing Date: 2025-03-31
Form: 8-K/A
Chunk 1
---
3 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

| Item 
 1.01 | Entry                                 
 into a Material Definitive Agreement. |

To the extent required, the discussion of the Subscription Agreement set forth in Item 3.02 below is incorporated by reference into this Item 1.01.

| Item 
 3.02 | Unregistered                
 Sales of Equity Securities. |

On March 26, 2025, PetVivo Holdings, Inc., including its wholly-owned subsidiary PetVivo Animal Health, Inc., (collectively the “Company”, “we” and “us”) entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock (“Shares”) (the “Offering”). The Company initially received Six Hundred Thousand Dollars ($600,000) of the Offering proceeds on March 26, 2025, with the investor receiving an option to invest the remaining Four Million Four Hundred Thousand Dollars ($4,400,000) pursuant to the same terms and conditions, which is anticipated to be received within the next sixty days of execution of the Subscription Agreement. The Offering was conducted pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”). The investor entered into the subscription agreement (the “Subscription Agreement”) with the Company and represented in writing that he, she, or it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act) and acquired the securities for his, her or its own account for investment purposes and any subsequent transfer or sales of these securities will be in accordance with the Securities Act or exempt from registration under the Securities Act. The shares of Series B Preferred Stock will be “restricted securities” under Rule 144 of the Securities Act, and certificates representing the foregoing will bear a Rule 144 restrictive legend.

The form of Subscription Agreement is filed as Exhibit 10.1 to this Current Report on Form 8